U.S. FDA approves Amylin's diabetes drug
WASHINGTON (Reuters) – Amylin Pharmaceuticals Inc won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly injectable Bydureon for treating adults with Type 2 diabetes, which is linked to poor diet and lack of exercise. Bydureon is a longer-acting form of …
Go to Source
Click Here To Check Out This what can diabetics eat Solution
No related posts.
Tags: Drug Administration, FDA
Leave a comment
Featured Resources
Free Diabetic Guide
Follow us on Twitter
- An error has occurred; the feed is probably down. Try again later.
Random Search Terms
- oxyelite pro duane reade
- how is the development of diabetes related to te breakdown of a feedback system
- newsmax spice cures diabetes
- societal and cultural influences that impact diabetes
- feedback mechanism when a carbohydrate rich meal is eaten
- oral thrush wont go away
- hot shaky faint
- sweet flemy saliva
- feedback mechanism of insulin and glucagon when a meal is eaten
- how to pass MEPS test with diabetes
Tags
ADD Additional Details ADHD ALWAYS American Diabetes Association Celiac Disease Diabetes Care DM Dreamfields Pasta Drug Administration ECG ED England EXTREMELY FAU FDA GD Gestational Diabetes Harvard Medical School HELP HIV India Joslin Diabetes Center Juvenile Diabetes LOT MEPS MS NASA New York NHS NOBODY Open Question Paula Deen Paul Garland PCOS POLL REALLY Resolved Question Stop Diabetes UK United States US USA UTI Wales